534 related articles for article (PubMed ID: 28120717)
21. Environment, epigenetics and neurodegeneration: Focus on nutrition in Alzheimer's disease.
Nicolia V; Lucarelli M; Fuso A
Exp Gerontol; 2015 Aug; 68():8-12. PubMed ID: 25456841
[TBL] [Abstract][Full Text] [Related]
22. Role of Long Non-coding RNAs in the Pathogenesis of Alzheimer's and Parkinson's Diseases.
Sivagurunathan N; Ambatt ATS; Calivarathan L
Curr Aging Sci; 2022; 15(2):84-96. PubMed ID: 35081899
[TBL] [Abstract][Full Text] [Related]
23. Epigenetic Modulation in Parkinson's Disease and Potential Treatment Therapies.
Rathore AS; Birla H; Singh SS; Zahra W; Dilnashin H; Singh R; Keshri PK; Singh SP
Neurochem Res; 2021 Jul; 46(7):1618-1626. PubMed ID: 33900517
[TBL] [Abstract][Full Text] [Related]
24. Epigenetic regulation of astrocyte function in neuroinflammation and neurodegeneration.
Neal M; Richardson JR
Biochim Biophys Acta Mol Basis Dis; 2018 Feb; 1864(2):432-443. PubMed ID: 29113750
[TBL] [Abstract][Full Text] [Related]
25. Epigenetics and DNA methylomic profiling in Alzheimer's disease and other neurodegenerative diseases.
Roubroeks JAY; Smith RG; van den Hove DLA; Lunnon K
J Neurochem; 2017 Oct; 143(2):158-170. PubMed ID: 28805248
[TBL] [Abstract][Full Text] [Related]
26. Low LDL cholesterol,
Benn M; Nordestgaard BG; Frikke-Schmidt R; Tybjærg-Hansen A
BMJ; 2017 Apr; 357():j1648. PubMed ID: 28438747
[No Abstract] [Full Text] [Related]
27. Gene therapy for Parkinson's and Alzheimer's diseases: from the bench to clinical trials.
Nobre RJ; Almeida LP
Curr Pharm Des; 2011; 17(31):3434-45. PubMed ID: 21902665
[TBL] [Abstract][Full Text] [Related]
28. PARP-1 involvement in neurodegeneration: A focus on Alzheimer's and Parkinson's diseases.
Martire S; Mosca L; d'Erme M
Mech Ageing Dev; 2015 Mar; 146-148():53-64. PubMed ID: 25881554
[TBL] [Abstract][Full Text] [Related]
29. Epigenetics of Alzheimer's Disease.
Nikolac Perkovic M; Videtic Paska A; Konjevod M; Kouter K; Svob Strac D; Nedic Erjavec G; Pivac N
Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33573255
[TBL] [Abstract][Full Text] [Related]
30. Alzheimer's disease: the potential of epigenetic treatments and current clinical candidates.
Coneys R; Wood IC
Neurodegener Dis Manag; 2020 Jun; 10(3):543-558. PubMed ID: 32552286
[TBL] [Abstract][Full Text] [Related]
31. Unlocking the epigenetic symphony: histone acetylation's impact on neurobehavioral change in neurodegenerative disorders.
Basavarajappa BS; Subbanna S
Epigenomics; 2024 Mar; 16(5):331-358. PubMed ID: 38321930
[TBL] [Abstract][Full Text] [Related]
32. Involvement of miRNA on epigenetics landscape of Parkinson's disease: From pathogenesis to therapeutics.
Uppala SN; Tryphena KP; Naren P; Srivastava S; Singh SB; Khatri DK
Mech Ageing Dev; 2023 Jul; 213():111826. PubMed ID: 37268278
[TBL] [Abstract][Full Text] [Related]
33. Epigenetics in neurodegeneration: a new layer of complexity.
Marques SC; Oliveira CR; Pereira CM; Outeiro TF
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):348-55. PubMed ID: 20736041
[TBL] [Abstract][Full Text] [Related]
34. The Role of DNA Methylation and Histone Modifications in Neurodegenerative Diseases: A Systematic Review.
Wen KX; Miliç J; El-Khodor B; Dhana K; Nano J; Pulido T; Kraja B; Zaciragic A; Bramer WM; Troup J; Chowdhury R; Ikram MA; Dehghan A; Muka T; Franco OH
PLoS One; 2016; 11(12):e0167201. PubMed ID: 27973581
[TBL] [Abstract][Full Text] [Related]
35. Cerebrospinal fluid biomarkers in Alzheimer's and Parkinson's diseases-From pathophysiology to clinical practice.
Blennow K; Biscetti L; Eusebi P; Parnetti L
Mov Disord; 2016 Jun; 31(6):836-47. PubMed ID: 27145480
[TBL] [Abstract][Full Text] [Related]
36. [Neuroepigenetics: Desoxyribonucleic acid methylation in Alzheimer's disease and other dementias].
Mendioroz Iriarte M; Pulido Fontes L; Méndez-López I
Med Clin (Barc); 2015 May; 144(10):457-64. PubMed ID: 24907105
[TBL] [Abstract][Full Text] [Related]
37. Neuroepigenetics of Aging and Age-Related Neurodegenerative Disorders.
Lardenoije R; Pishva E; Lunnon K; van den Hove DL
Prog Mol Biol Transl Sci; 2018; 158():49-82. PubMed ID: 30072060
[TBL] [Abstract][Full Text] [Related]
38. Research progress of epigenetic biomarkers in the early diagnosis and treatment of human diseases.
Li W; Qin J; Wang H; Chen LB
Yi Chuan; 2018 Feb; 40(2):104-115. PubMed ID: 29428903
[TBL] [Abstract][Full Text] [Related]
39. Multidisciplinary perspectives for Alzheimer's and Parkinson's diseases: hydrogels for protein delivery and cell-based drug delivery as therapeutic strategies.
Giordano C; Albani D; Gloria A; Tunesi M; Batelli S; Russo T; Forloni G; Ambrosio L; Cigada A
Int J Artif Organs; 2009 Dec; 32(12):836-50. PubMed ID: 20037888
[TBL] [Abstract][Full Text] [Related]
40. Epigenetic Biomarkers for Parkinson's Disease: From Diagnostics to Therapeutics.
Jakubowski JL; Labrie V
J Parkinsons Dis; 2017; 7(1):1-12. PubMed ID: 27792016
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
